Home
About Us
Evaluation method
Selection criteria
Benefits
Evaluation procedure
Checklist
Journals
Submit Journal
All Journals
Indexed Journals
Journals by country
Contact Us
Login / Register
Please search here and press enter...
Onco Critical Care
Journal title :
Onco Critical Care
Online-Issn No :
3048-6289
Print-Issn No :
Language :
English
Publisher :
IP Innovative Publication Pvt. Ltd.
Issue and Contents
Volume 1
Volume 1 issue 1
Volume 1 issue 2
Volume 1 issue 3
Volume 2
Volume 2 issue 1
Volume 2 issue 2
Ulinastatin is an immuno modulator in COVID associated cytokine storm storm: A retrospective observational study
Page No:
18-22
DOI:
10.18231/j.occ.2024.006
Ulinastatin is an immuno modulator in COVID associated cytokine storm storm: A retrospective observational study
Page No:
18-22
DOI:
10.18231/j.occ.2024.006
Seroprevalence of Australian antigen (HBsAg) among blood donors in the local population at standalone blood center by ELISA and rapid test kit
Page No:
23-29
DOI:
10.18231/j.occ.2024.007
Seroprevalence of Australian antigen (HBsAg) among blood donors in the local population at standalone blood center by ELISA and rapid test kit
Page No:
23-29
DOI:
10.18231/j.occ.2024.007
An unusual presentation of encephalopathy due to tumor lysis syndrome in multiple myeloma A case report
Page No:
30-32
DOI:
10.18231/j.occ.2024.008
An unusual presentation of encephalopathy due to tumor lysis syndrome in multiple myeloma A case report
Page No:
30-32
DOI:
10.18231/j.occ.2024.008
A Primary Gastric neuroendocrine tumour (GNET): A rare entity
Page No:
33-37
DOI:
10.18231/j.occ.2024.009
A Primary Gastric neuroendocrine tumour (GNET): A rare entity
Page No:
33-37
DOI:
10.18231/j.occ.2024.009
Bullous lesion in lepromatous leprosy -A rare case with review of literature
Page No:
38-41
DOI:
10.18231/j.occ.2024.010
Bullous lesion in lepromatous leprosy -A rare case with review of literature
Page No:
38-41
DOI:
10.18231/j.occ.2024.010
Risk factors for Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
Page No:
42-44
DOI:
10.18231/j.occ.2024.011
Risk factors for Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
Page No:
42-44
DOI:
10.18231/j.occ.2024.011